Publications

Showing

0

out of

0

results

Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis.

Hartung HP, Berger T, Bermel RA,

January 10, 2020

FLAME: A computerized neuropsychological composite for trials in early Cognitive impairment and dementia

Brooker H, et al.

January 9, 2020

The association of stroke severity with health-related quality of life in survivors of acute cerebrovascular disease and their informal caregivers during the first year post stroke: a survey study.

Labberton AS, Augestad LA, Thommessen B

January 9, 2020

Incidence and Mortality of Cerebral Venous Thrombosis in a Norwegian Population.

Kristoffersen ES, Harper CE, Vetvik KG

January 9, 2020

Effects of Purified Anthocyanins in People at Risk for Cognitive impairment and dementia: Study Protocol for a Phase II Randomized Controlled Trial

Khalifa K, et al.

January 8, 2020

Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke: The Global COVID-19 Stroke Registry.

Ntaios G, Michel P, Georgiopoulos

January 8, 2020

Predictive and diagnostic utility of brief neuropsychological assessment in detecting Alzheimer’s pathology and progression to Cognitive impairment and dementia

Eliassen IV, et al.

January 7, 2020

The effects of a dialogue-based intervention to promote psychosocial well-being after stroke: a randomized controlled trial.

Bragstad LK, Hjelle EG, Zucknick M,

January 7, 2020

European Academy of Neurology guideline on the management of medication-overuse headache.

Diener HC, Antonaci F, Braschinsky M,

January 6, 2020

Analyzing microglial-associated Aβ in Alzheimer's disease transgenic mice with a novel mid-domain Aβ-antibody

Henjum K, et al.

January 5, 2020